News & Insights

01 Mar Seqel Appoints Mark Fletcher as Chief Science Officer at Douglas Pharmaceuticals Ltd

Douglas Pharmaceuticals, New Zealand’s largest pharmaceutical development and manufacturing company in Oceania, appoints Mark Fletcher as Chief Science Officer. Mark has migrated from the United States, previously being employed as VP Technical Operations & Regulatory Affairs for PBM Pharmaceuticals. He has a global pedigree background…

Read More

01 Sep Breaking into the Boardroom

SEQEL Partner, Mark Ashcroft comments on the increasing number of young female directors adopting a portfolio approach to life in the September 20th National Business Review. The article includes profiles of 4 prominent young directors; Alison Taylor, Vanessa Stoddart, Vicky Taylor and Rukumoana Schaafhausen. Click…

Read More